Resveratrol as a supplemental therapeutic in cardiovascular and metabolic syndromes: A critical review

Stephen Esker, Antora Banerjee, Tessa M. Simone, Christine A. Gallati, Shaker A. Mousa

Research output: Contribution to journalReview article

3 Citations (Scopus)

Abstract

Metabolic syndrome places patients at high risk to many other health problems, as their bodies are in a perpetual state pro-inflammation and pro-thrombosis. In many cases, a regulated diet and increased exercise is sufficient in rectifying their condition, however for many patients, drug intervention is necessary. In recent years, calorie restriction has been shown to improve the health of patients afflicted with aging-related diseases, specifically those associated with metabolic syndrome, and researchers are now exploring drugs that mimic calorie restriction. Resveratrol mimics a calorie restricted diet as it has been shown to attenuate health benefits, including anti-platelet aggregation, vasorelaxation, atherosclerosis suppression, and lipid metabolism similar to a calorie restricted diet. Additionally, it modulates many of the pathways associated with metabolic syndrome, leading researchers to believe it has potential as a burgeoning therapeutic approach.

Original languageEnglish (US)
Pages (from-to)1-8
Number of pages8
JournalCurrent Nutrition and Food Science
Volume5
Issue number1
DOIs
StatePublished - Feb 1 2009

Fingerprint

Metabolic Syndrome X
resveratrol
metabolic syndrome
low calorie diet
Diet
therapeutics
researchers
Research Personnel
drugs
vasodilation
platelet aggregation
thrombosis
Health
Insurance Benefits
atherosclerosis
Platelet Aggregation
Lipid Metabolism
Vasodilation
lipid metabolism
Pharmaceutical Preparations

All Science Journal Classification (ASJC) codes

  • Food Science
  • Nutrition and Dietetics
  • Public Health, Environmental and Occupational Health

Cite this

Esker, Stephen ; Banerjee, Antora ; Simone, Tessa M. ; Gallati, Christine A. ; Mousa, Shaker A. / Resveratrol as a supplemental therapeutic in cardiovascular and metabolic syndromes : A critical review. In: Current Nutrition and Food Science. 2009 ; Vol. 5, No. 1. pp. 1-8.
@article{b6f8ca345ffb4c0abb2cffec4b537dd6,
title = "Resveratrol as a supplemental therapeutic in cardiovascular and metabolic syndromes: A critical review",
abstract = "Metabolic syndrome places patients at high risk to many other health problems, as their bodies are in a perpetual state pro-inflammation and pro-thrombosis. In many cases, a regulated diet and increased exercise is sufficient in rectifying their condition, however for many patients, drug intervention is necessary. In recent years, calorie restriction has been shown to improve the health of patients afflicted with aging-related diseases, specifically those associated with metabolic syndrome, and researchers are now exploring drugs that mimic calorie restriction. Resveratrol mimics a calorie restricted diet as it has been shown to attenuate health benefits, including anti-platelet aggregation, vasorelaxation, atherosclerosis suppression, and lipid metabolism similar to a calorie restricted diet. Additionally, it modulates many of the pathways associated with metabolic syndrome, leading researchers to believe it has potential as a burgeoning therapeutic approach.",
author = "Stephen Esker and Antora Banerjee and Simone, {Tessa M.} and Gallati, {Christine A.} and Mousa, {Shaker A.}",
year = "2009",
month = "2",
day = "1",
doi = "10.2174/157340109787314785",
language = "English (US)",
volume = "5",
pages = "1--8",
journal = "Current Nutrition and Food Science",
issn = "1573-4013",
publisher = "Bentham Science Publishers B.V.",
number = "1",

}

Resveratrol as a supplemental therapeutic in cardiovascular and metabolic syndromes : A critical review. / Esker, Stephen; Banerjee, Antora; Simone, Tessa M.; Gallati, Christine A.; Mousa, Shaker A.

In: Current Nutrition and Food Science, Vol. 5, No. 1, 01.02.2009, p. 1-8.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Resveratrol as a supplemental therapeutic in cardiovascular and metabolic syndromes

T2 - A critical review

AU - Esker, Stephen

AU - Banerjee, Antora

AU - Simone, Tessa M.

AU - Gallati, Christine A.

AU - Mousa, Shaker A.

PY - 2009/2/1

Y1 - 2009/2/1

N2 - Metabolic syndrome places patients at high risk to many other health problems, as their bodies are in a perpetual state pro-inflammation and pro-thrombosis. In many cases, a regulated diet and increased exercise is sufficient in rectifying their condition, however for many patients, drug intervention is necessary. In recent years, calorie restriction has been shown to improve the health of patients afflicted with aging-related diseases, specifically those associated with metabolic syndrome, and researchers are now exploring drugs that mimic calorie restriction. Resveratrol mimics a calorie restricted diet as it has been shown to attenuate health benefits, including anti-platelet aggregation, vasorelaxation, atherosclerosis suppression, and lipid metabolism similar to a calorie restricted diet. Additionally, it modulates many of the pathways associated with metabolic syndrome, leading researchers to believe it has potential as a burgeoning therapeutic approach.

AB - Metabolic syndrome places patients at high risk to many other health problems, as their bodies are in a perpetual state pro-inflammation and pro-thrombosis. In many cases, a regulated diet and increased exercise is sufficient in rectifying their condition, however for many patients, drug intervention is necessary. In recent years, calorie restriction has been shown to improve the health of patients afflicted with aging-related diseases, specifically those associated with metabolic syndrome, and researchers are now exploring drugs that mimic calorie restriction. Resveratrol mimics a calorie restricted diet as it has been shown to attenuate health benefits, including anti-platelet aggregation, vasorelaxation, atherosclerosis suppression, and lipid metabolism similar to a calorie restricted diet. Additionally, it modulates many of the pathways associated with metabolic syndrome, leading researchers to believe it has potential as a burgeoning therapeutic approach.

UR - http://www.scopus.com/inward/record.url?scp=70350627551&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70350627551&partnerID=8YFLogxK

U2 - 10.2174/157340109787314785

DO - 10.2174/157340109787314785

M3 - Review article

AN - SCOPUS:70350627551

VL - 5

SP - 1

EP - 8

JO - Current Nutrition and Food Science

JF - Current Nutrition and Food Science

SN - 1573-4013

IS - 1

ER -